| CAS ID: | 58-32-2 |
| Molecular Formula: | C24H40N8O4 |
| Molecular Weight: | 504.6 g/mol |
| Monoisotopic Mass: | 504.3173 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | MODAPLATE | IV PERSANTINE | CEREBROVASE 25 | ATTIA | CEREBROVASE 100 | PYRIDANTIN | PERSANTINE | PERSANTIN RET | OFCRAM PR | DIPYRIDAMOLE | PERSANTIN | VASYROL | RA-8 |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 11380836 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,rat | Fibrosis Disease | Peritoneal fibrosis |
| Process I | |||
| Process II | cells proliferation | ||
| Process III | |||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT02247414 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | September 25, 2014 | Last Verified | November 6, 2017 |
| Sponsor | Yangzhou University | ||
Trial Record 2
| ClinicalTrial ID | NCT02238444 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Recruiting |
| First Received | September 12, 2014 | Last Verified | January 1, 2019 |
| Sponsor | Yangzhou University | ||